- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 204-218 of
573 results
1021 Exhibit: Ex 1021 US Application No 11553,339, Final Office Action mailed Dec...
Document
IPR2017-01101, No. 1021-20 Exhibit - Ex 1021 US Application No 11553,339, Final Office Action mailed Dec 31, 2009 (P.T.A.B. Apr. 4, 2017)
|
|
Cite Document
1015 Exhibit: Ex 1015 Patient Information Leaflet, ABRAXANE for Injectable Suspe...
Document
IPR2017-01101, No. 1015-14 Exhibit - Ex 1015 Patient Information Leaflet, ABRAXANE for Injectable Suspension paclitaxel protein bound particles for injectable suspension albumin bound rev...
|
|
Cite Document
1025 Exhibit: Ex 1025 FDA, Approved Drug Products with Therapeutic Equivalence...
Document
IPR2017-01101, No. 1025-24 Exhibit - Ex 1025 FDA, Approved Drug Products with Therapeutic Equivalence Evaluations 33d ed 2013 Orange Book (P.T.A.B. Apr. 4, 2017)
|
|
Cite Document
2026 Exhibit: Exhibit 2026
Document
IPR2017-01101, No. 2026-52 Exhibit - Exhibit 2026 (P.T.A.B. Jul. 12, 2017)
|
|
Cite Document
2031 Exhibit: Exhibit 2031
Document
IPR2017-01101, No. 2031-57 Exhibit - Exhibit 2031 (P.T.A.B. Jul. 12, 2017)
|
|
Cite Document
1026 Exhibit: Ex 1026 Desai et al, US Patent No 5,916,596 issued Jun 29, 1999
Document
IPR2017-01101, No. 1026-25 Exhibit - Ex 1026 Desai et al, US Patent No 5,916,596 issued Jun 29, 1999 (P.T.A.B. Apr. 4, 2017)
|
|
Cite Document
2065 Exhibit: Exhibit 2065 Declaration of Daniel C Wiesner IPR2014 01101
Document
IPR2017-01101, No. 2065-92 Exhibit - Exhibit 2065 Declaration of Daniel C Wiesner IPR2014 01101 (P.T.A.B. Nov. 8, 2017)
|
|
Cite Document
2045 Exhibit: Exhibit 2045
Document
IPR2017-01101, No. 2045-71 Exhibit - Exhibit 2045 (P.T.A.B. Jul. 12, 2017)
|
|
Cite Document
2032 Exhibit: Exhibit 2032
Document
IPR2017-01101, No. 2032-58 Exhibit - Exhibit 2032 (P.T.A.B. Jul. 12, 2017)
|
|
Cite Document
1018 Exhibit: Ex 1018 Ibrahim et al, Phase I and pharmacokinetic study of ABI 007...
Document
IPR2017-01101, No. 1018-17 Exhibit - Ex 1018 Ibrahim et al, Phase I and pharmacokinetic study of ABI 007, a Cremo phor free, protein stabilized, nanoparticle formulation of paclitaxel, Clin Can...
|
|
Cite Document
1003 Exhibit: Ex 1003 Desai et al, US Patent No 5,439,686
Document
IPR2017-01101, No. 1003-2 Exhibit - Ex 1003 Desai et al, US Patent No 5,439,686 (P.T.A.B. Apr. 4, 2017)
|
|
Cite Document
